Genprex
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -2 | ||
EBITDA | -4,322 | -6,515 | |
EBIT | -4,323 | -6,518 | |
Net Income | -4,330 | -4,315 | -6,495 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,869 | -2,168 | -5,778 |
Cash | 1,601 | 1,488 | 2,459 |
Basic Shares | 8,508 | 3,499 | 2,161 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -23,830 | -22 | |
EBITDA | -31,060 | -23,805 | -20,647 | |
EBIT | -31,075 | -23,830 | -20,670 | |
Net Income | -21,388,282 | -30,860 | -29,463 | -19,590 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,149,088 | -24,809 | -17,838 | -14,368 |
Cash | 1,601 | 6,737 | 20,954 | 38,628 |
Basic Shares | 4,005 | 1,367 | 1,198 | 1,177 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.42 |
2024-09-30 | -$1.23 |
2024-06-30 | -$3 |
2024-03-31 | -$3.69 |
